VASCVERSA
Live / Applied — Non-final action mailed (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 30 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79436736
- Mark type
- Stylized text
- Filed
- 30 Sept 2025
Goods and services
- Class 001 — Chemicals: Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use.
- Class 005 — Pharmaceuticals: Pharmaceuticals; drugs for medical purposes; stem cells; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; vaccines, reagents for medical use; medical diagnostic reagents; biological tissue cultures for medical purposes; human allograft tissue; tissues for medical use; vascular grafts; sponges for healing wounds.
- Class 010 — Medical apparatus: Medical devices; medical apparatus; medical instruments; apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair; medical devices and apparatus for cell therapy; blood testing equipment; blood testing apparatus; artificial vascular grafts.
- Class 042 — Scientific and technological services: Medical and pharmacological research services; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research in the field of cell engineering technology; research in the field of vascular regeneration and repair; research and development of medicines; pharmaceutical drug development services; drug discovery services; development of pharmaceutical preparations and medicines; development of cell therapies; research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; clinical trials; blood analysis services; gene therapy research; information, advisory and consultancy services in relation to all of the aforesaid services.
- Class 044 — Medical, beauty and agricultural services: Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; medical services relating to the removal, treatment and processing of stem cells; stem cell storage; human cell storage; cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; medical analysis services; services for the testing of blood; medical services relating to the removal, treatment and processing of human blood; information, advisory and consultancy services in relation to all of the aforesaid services.
Owner
Prosecution history
- 02 Apr 2026 — REFUSAL PROCESSED BY IB
- 17 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Mar 2026 — REFUSAL PROCESSED BY MPU
- 05 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 11 Feb 2026 — NON-FINAL ACTION WRITTEN
- 04 Feb 2026 — ASSIGNED TO EXAMINER
- 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB